347 related articles for article (PubMed ID: 29563006)
1. Opioid Rotation in Cancer Pain Treatment.
Schuster M; Bayer O; Heid F; Laufenberg-Feldmann R
Dtsch Arztebl Int; 2018 Mar; 115(9):135-142. PubMed ID: 29563006
[TBL] [Abstract][Full Text] [Related]
2. Opioids for cancer pain - an overview of Cochrane reviews.
Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
[TBL] [Abstract][Full Text] [Related]
3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
4. [Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
Vieira C; Brás M; Fragoso M
Acta Med Port; 2019 May; 32(5):388-399. PubMed ID: 31166900
[TBL] [Abstract][Full Text] [Related]
5. Pediatric palliative care: use of opioids for the management of pain.
Zernikow B; Michel E; Craig F; Anderson BJ
Paediatr Drugs; 2009; 11(2):129-51. PubMed ID: 19301934
[TBL] [Abstract][Full Text] [Related]
6. [Opioid switch and change of route of administration in cancer patients treated by morphine].
Michenot N; Rostaing S; Baron L; Faure S; Jovenin N; Hubault P; Delorme T; Collin E; Filbet M; Chvetzoff G; Delorme C; Minello C; Magnet M; Ammar D; Krakowski I; Poulain P
Bull Cancer; 2018 Nov; 105(11):1052-1073. PubMed ID: 30274680
[TBL] [Abstract][Full Text] [Related]
7. Opioid rotation in the treatment of joint pain. A review of 67 cases.
Grilo RM; Bertin P; Scotto di Fazano C; Coyral D; Bonnet C; Vergne P; Treves R
Joint Bone Spine; 2002 Oct; 69(5):491-4. PubMed ID: 12477234
[TBL] [Abstract][Full Text] [Related]
8. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Takemura M; Niki K; Okamoto Y; Matsuda Y; Omae T; Takagi T; Ueda M
Biol Pharm Bull; 2021; 44(9):1286-1293. PubMed ID: 34471056
[TBL] [Abstract][Full Text] [Related]
9. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study.
Lawlor P; Turner K; Hanson J; Bruera E
Pain; 1997 Aug; 72(1-2):79-85. PubMed ID: 9272790
[TBL] [Abstract][Full Text] [Related]
10. Opioid rotation for cancer pain: rationale and clinical aspects.
Mercadante S
Cancer; 1999 Nov; 86(9):1856-66. PubMed ID: 10547561
[TBL] [Abstract][Full Text] [Related]
11. Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Gálvez R; Schäfer M; Hans G; Falke D; Steigerwald I
Adv Ther; 2013 Mar; 30(3):229-59. PubMed ID: 23475406
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
13. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
[TBL] [Abstract][Full Text] [Related]
14. Influence of serum albumin levels during opioid rotation from morphine or oxycodone to fentanyl for cancer pain.
Hayashi T; Ikehata S; Matsuzaki H; Yasuda K; Makihara T; Futamura A; Arakawa Y; Kuki R; Fukuura K; Takahashi H; Mori N; Higashiguchi T; Yamadaa S
Biol Pharm Bull; 2014; 37(12):1860-5. PubMed ID: 25590058
[TBL] [Abstract][Full Text] [Related]
15. Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature.
Jackson LD; Wortzman R; Chua D; Selby D
J Oncol Pharm Pract; 2021 Jan; 27(1):238-243. PubMed ID: 32501183
[TBL] [Abstract][Full Text] [Related]
16. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
Juba KM; Wahler RG; Daron SM
J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
[TBL] [Abstract][Full Text] [Related]
17. Practices and perceptions regarding intravenous opioid infusion and cancer pain management.
Arthur JA; Reddy A; Smith U; Hui D; Park M; Liu D; Vaughan-Adams N; Haider A; Williams J; Bruera E
Cancer; 2019 Nov; 125(21):3882-3889. PubMed ID: 31291011
[TBL] [Abstract][Full Text] [Related]
18. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study.
Takemura M; Niki K; Okamoto Y; Kawamura T; Kohno M; Matsuda Y; Ikeda K
J Pain Symptom Manage; 2024 Jan; 67(1):39-49.e5. PubMed ID: 37757956
[TBL] [Abstract][Full Text] [Related]
20. Changes in trends and pattern of strong opioid prescribing in primary care.
Zin CS; Chen LC; Knaggs RD
Eur J Pain; 2014 Oct; 18(9):1343-51. PubMed ID: 24756859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
